Workflow
Prediction: The Data Center Boom Is Just Starting, Making AMD a Long-Term AI Power Player
The Motley Fool· 2025-12-02 03:05
AMD could be one of the biggest semiconductor stock winners over the next few years.Perhaps one of the most overlooked players in the artificial intelligence (AI) infrastructure buildout right now is Advanced Micro Devices (AMD +1.12%). And truthfully, the company is being overshadowed at the moment.Nvidia (NVDA +1.50%) grabs most of the headlines, and rightfully so, given its size and massive growth. The company is the clear leader in the data center graphics processing unit (GPU) space, with over 90% mark ...
ROSEN, A TOP-RANKED LAW FIRM, Encourages America's Car-Mart, Inc. Investors to Inquire About Securities Class Action Investigation - CRMT
Newsfile· 2025-12-02 03:02
New York, New York--(Newsfile Corp. - December 1, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of America's Car-Mart, Inc. (NASDAQ: CRMT) resulting from allegations that America's Car-Mart may have issued materially misleading business information to the investing public.SO WHAT: If you purchased America's Car-Mart securities you may be entitled to compensation without payment of any out of pocket fees or cost ...
Ross Stores, Inc. (NASDAQ:ROST) Receives Upgrade from Jefferies
Financial Modeling Prep· 2025-12-02 03:00
Jefferies upgraded Ross Stores, Inc. (NASDAQ:ROST) to a "Buy" rating and increased the price target from $190 to $205.The Zacks Rank #2 (Buy) rating for Ross Stores indicates a positive outlook on the company's earnings prospects.With a current price of $177.50 and a market capitalization of approximately $57.73 billion, Ross Stores shows strong investor interest and potential for growth.Ross Stores, Inc. (NASDAQ:ROST) is a prominent player in the off-price retail sector, offering a wide range of apparel, f ...
Disney's Succession Race Enters Final Stage as Iger's Reign Draws to End
WSJ· 2025-12-02 03:00
Core Viewpoint - The company is expected to promote from within for its leadership positions, with Josh D'Amaro and Dana Walden as leading candidates [1] Group 1 - Parks chief Josh D'Amaro is considered a leading contender for promotion [1] - Television head Dana Walden is also viewed as a strong candidate for leadership roles [1]
Mitsubishi Electric to Launch Two New XB Series HVIGBT Modules
Businesswire· 2025-12-02 03:00
Dec 1, 2025 10:00 PM Eastern Standard Time Mitsubishi Electric to Launch Two New XB Series HVIGBT Modules Share Contacts Customer InquiriesSemiconductor & Device Marketing Div.AMitsubishi Electric Corporationwww.MitsubishiElectric.com/semiconductors/ Media InquiriesTakeyoshi KomatsuPublic Relations DivisionMitsubishi Electric CorporationTel: +81-3-3218- 2332prd.gnews@nk.MitsubishiElectric.co.jpwww.MitsubishiElectric.com/en/pr/ Industry: Mitsubishi Electric Corporation TOKYO:6503 Release Versions English For ...
Samsung's Next Salvo Against Apple: A Triple-Folding Smartphone
WSJ· 2025-12-02 02:43
Group 1 - The article highlights the introduction of the Galaxy Z TriFold, which is the first device in the U.S. market that folds inward twice like a pamphlet [1]
MLTX DEADLINE: ROSEN, A TOP-RANKED LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action - MLTX
Newsfile· 2025-12-02 02:41
Core Viewpoint - Rosen Law Firm is encouraging investors of MoonLake Immunotherapeutics to secure legal counsel before the December 15, 2025 deadline for a securities class action lawsuit related to the company's stock performance during the specified class period [1][2]. Group 1: Class Action Details - Investors who purchased MoonLake common stock between March 10, 2024, and September 29, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - The lawsuit alleges that the defendants made false and misleading statements regarding the efficacy of their product SLK compared to traditional monoclonal antibodies, leading to investor damages when the truth was revealed [5]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of successful settlements in securities class actions, including the largest settlement against a Chinese company and significant recoveries for investors in recent years [4].
Exelon Prices Offering of $900 Million of 3.25% Convertible Senior Notes due 2029
Businesswire· 2025-12-02 02:40
Core Viewpoint - Exelon Corporation has announced the pricing of its offering of $900 million in 3.25% convertible senior notes due 2029, indicating a strategic move to raise capital through a private placement under the Securities Act of 1933 [1] Group 1 - The total principal amount of the convertible senior notes being offered is $900 million [1] - The notes have a fixed interest rate of 3.25% and are set to mature in 2029 [1] - Exelon has provided initial purchasers of the convertible notes with an option to purchase additional notes within a 13-day period from the issuance date [1]
Sunrun Stock Has Surged 61% in a Year — So Why Did One Investor Sell 300,000 Shares?
The Motley Fool· 2025-12-02 02:39
Sunrun’s big rebound is gaining traction—but does Canyon’s move suggest the recovery is still fragile?Dallas-based Canyon Capital Advisors reported on November 14 that it sold 300,000 shares of Sunrun in the third quarter. The fund’s position value fell by approximately $13 million from quarter to quarter.What HappenedCanyon Capital Advisors disclosed in its Securities and Exchange Commission (SEC) Form 13F filing on November 14 that it reduced its stake in Sunrun (RUN 8.37%) by 300,000 shares during the th ...
MOH DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Molina Healthcare, Inc. Investors to Secure Counsel Before Important December 2 Deadline in Securities Class Action - MOH
Newsfile· 2025-12-02 02:36
Core Viewpoint - Molina Healthcare, Inc. is facing a securities class action lawsuit due to alleged failures in disclosing material adverse facts regarding its financial health and operational assumptions during the class period from February 5, 2025, to July 23, 2025 [2][6]. Group 1: Class Action Details - The Rosen Law Firm is encouraging investors who purchased Molina securities during the specified class period to secure legal counsel before the December 2, 2025, lead plaintiff deadline [2][4]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and potential lead plaintiffs must act by the deadline to represent other class members [4][8]. Group 2: Allegations Against Molina Healthcare - The lawsuit claims that Molina failed to disclose critical information, including adverse facts about its medical cost trend assumptions and the dislocation between premium rates and medical costs [6]. - It is alleged that Molina's near-term growth relied on a lack of utilization of various health services, which could lead to a significant cut in its financial guidance for fiscal year 2025 [6]. - The lawsuit asserts that the positive statements made by Molina regarding its business and prospects were materially misleading and lacked a reasonable basis [6]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked highly for settlements since 2013 [5]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [5]. - The firm emphasizes the importance of selecting qualified counsel with a proven success record in leading securities class actions [5].